Browse drugs

…een 1L and second-line (2L) therapies) was twice as long versus sunitinib. TFS and survival states for ICI plus vascular endothelial grow…

…) had lung metastases. The most frequently prescribed TKIs were cabozantinib (n=31), dabrafenib (n=25), and lenvatinib (n=17). 48% of patien…

…patient in sitravatinib+tislelizumab arm; 13 (6.8%) patients in docetaxel arm) (figure 1). One patient randomised to sitravatinib+tisleli…

…nd addressing the adverse effects of targeted therapies such as cabozantinib.…

…tor cabozantinib and the anti-PD-L1 immune checkpoint inhibitor nivolumab in patients with unresectable HCC ( NCT03299946). Major patholo…

…static MTC. In the setting of progressive metastatic MTC, TKIs (selpercatinib, cabozantinib and vandetanib) can prolong survival for some pat…

…c MGMT-deficient G1/G2 PanNET treated with TMZ, with or without capecitabine, reportedly experienced histological progression to G3 disease …

…an age was 63.8 years. The most common first-line regimens were nivolumab (N) + cabozantinib (44.1%), N + ipilimumab (26.5%), pembrolizum…

…8Ga]Ga-PSMA are prognostic correlates with therapy response for cabozantinib, a VEGF inhibitor, for ccRCC.72 In RCC, ccRCC shows the highest…